Specialty Area
Spotlight
Topics
Institute for Value-Based Medicine
About AJMC
Podcasts
CE
Subscribe
- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Biosimilars Unveiled: Current Trends, Challenges, and Future Opportunities in the US Marketplace : Episode 14
Legislative Support for Biosimilars
The expert panel discuss the importance of legislative support to continue innovations in the biosimilar space.
EP: 1.Biologics Utilization Impacting US Health Care Spending
EP: 2.Current Landscape of Biosimilar Use in US Healthcare Space
EP: 3.Interchangeability Impacting Biosimilar Uptake
EP: 4.The Impact of Payer Coverage and Reimbursement on Biosimilars
EP: 5.Navigating Biosimilar Uptake in New Patients
EP: 6.Economic Impacts and Pricing Strategies Surrounding Biosimilars
EP: 7.Private Label Biosimilars
EP: 8.Biosimilars in the Commercial Sector
EP: 9.The Influence of Employer Preferences And Adoption of Biosimilars
EP: 10.Out of Pocket Costs Associated with Biosimilar Use
EP: 11.Unmet Needs and Future Initiatives
EP: 12.Ideal Goals for Biosimilar Utilization
EP: 13.Foreseeable Biosimilar Trends
Now Viewing
EP: 14.Legislative Support for Biosimilars
EP: 15.Key Takeaways for Biosimilar Utilization
Video content above is prompted by the following:
- In an ideal scenario, what would legislative support for biosimilars entail? Is it feasible in the near future for federal or state laws to promote or require that payers cover all biosimilars?
Related Videos
